Arcutis Biotherapeutics (ARQT) Total Debt: 2021-2025
Historic Total Debt for Arcutis Biotherapeutics (ARQT) over the last 4 years, with Sep 2025 value amounting to $108.5 million.
- Arcutis Biotherapeutics' Total Debt fell 46.97% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.5 million, marking a year-over-year decrease of 46.97%. This contributed to the annual value of $107.2 million for FY2024, which is 46.88% down from last year.
- Per Arcutis Biotherapeutics' latest filing, its Total Debt stood at $108.5 million for Q3 2025, which was up 0.42% from $108.0 million recorded in Q2 2025.
- Arcutis Biotherapeutics' 5-year Total Debt high stood at $204.6 million for Q3 2024, and its period low was $72.3 million during Q4 2021.
- Over the past 3 years, Arcutis Biotherapeutics' median Total Debt value was $199.8 million (recorded in 2023), while the average stood at $167.6 million.
- As far as peak fluctuations go, Arcutis Biotherapeutics' Total Debt surged by 173.35% in 2022, and later plummeted by 46.98% in 2025.
- Quarterly analysis of 5 years shows Arcutis Biotherapeutics' Total Debt stood at $72.3 million in 2021, then skyrocketed by 173.35% to $197.8 million in 2022, then climbed by 2.04% to $201.8 million in 2023, then crashed by 46.88% to $107.2 million in 2024, then plummeted by 46.97% to $108.5 million in 2025.
- Its Total Debt stands at $108.5 million for Q3 2025, versus $108.0 million for Q2 2025 and $107.6 million for Q1 2025.